Senores Pharmaceuticals Limited (BOM:544319)

Market Cap	36.09B +54.2%
Revenue (ttm)	5.53B +43.2%
Net Income	1.02B +79.3%
EPS	22.43 +40.3%
Shares Out	n/a
PE Ratio	35.52
Forward PE	26.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,756
Average Volume	11,584
Open	793.05
Previous Close	802.75
Day's Range	781.00 - 799.95
52-Week Range	457.95 - 876.00
Beta	n/a
RSI	42.71
Earnings Date	Jan 20, 2026

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supp...

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 194
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544319

Financial Performance

In fiscal year 2025, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.65% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.20%.